{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:33:16Z","timestamp":1760189596783},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/aje\/kwx359","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T20:18:18Z","timestamp":1510690698000},"page":"777-785","source":"Crossref","is-referenced-by-count":15,"title":["Long-Term Risk of Cardiovascular Death With Use of Clarithromycin and Roxithromycin: A Nationwide Cohort Study"],"prefix":"10.1093","volume":"187","author":[{"given":"Malin","family":"Inghammar","sequence":"first","affiliation":[{"name":"Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark"},{"name":"Division of Infection Medicine, Sk\u00e5ne University Hospital and Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Nibell","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark"},{"name":"Division of Infection Medicine, Sk\u00e5ne University Hospital and Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Pasternak","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark"},{"name":"Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads","family":"Melbye","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark"},{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Svanstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hviid","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"issue":"20","key":"key\n\t\t\t\t20180403061358_kwx359C1","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","article-title":"The role of macrolide antibiotics in increasing cardiovascular risk","volume":"66","author":"Cheng","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"key\n\t\t\t\t20180403061358_kwx359C2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJMp1302726","article-title":"Cardiovascular risks with azithromycin and other antibacterial drugs","volume":"368","author":"Mosholder","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"key\n\t\t\t\t20180403061358_kwx359C3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1086\/508873","article-title":"Antimicrobial-associated QT interval prolongation: pointes of interest","volume":"43","author":"Owens","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"key\n\t\t\t\t20180403061358_kwx359C4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciu914","article-title":"Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and \u03b2-lactam\/\u03b2-lactamase inhibitors: a Taiwanese nationwide study","volume":"60","author":"Chou","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"key\n\t\t\t\t20180403061358_kwx359C5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1370\/afm.1601","article-title":"Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death","volume":"12","author":"Rao","year":"2014","journal-title":"Ann Fam Med"},{"issue":"20","key":"key\n\t\t\t\t20180403061358_kwx359C6","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t20180403061358_kwx359C7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa040582","article-title":"Oral erythromycin and the risk of sudden death from cardiac causes","volume":"351","author":"Ray","year":"2004","journal-title":"N Engl J Med"},{"issue":"18","key":"key\n\t\t\t\t20180403061358_kwx359C8","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1300799","article-title":"Use of azithromycin and death from cardiovascular causes","volume":"368","author":"Svanstr\u00f6m","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180403061358_kwx359C9","doi-asserted-by":"crossref","first-page":"g4930","DOI":"10.1136\/bmj.g4930","article-title":"Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study","volume":"349","author":"Svanstr\u00f6m","year":"2014","journal-title":"BMJ"},{"issue":"7532","key":"key\n\t\t\t\t20180403061358_kwx359C10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.38666.653600.55","article-title":"Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial","volume":"332","author":"Jespersen","year":"2006","journal-title":"BMJ"},{"issue":"21","key":"key\n\t\t\t\t20180403061358_kwx359C11","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/jama.293.21.2641","article-title":"Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials","volume":"293","author":"Andraws","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"key\n\t\t\t\t20180403061358_kwx359C12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0828-282X(08)70603-2","article-title":"A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases","volume":"24","author":"Song","year":"2008","journal-title":"Can J Cardiol"},{"issue":"11","key":"key\n\t\t\t\t20180403061358_kwx359C13","first-page":"CD009764","article-title":"Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)","author":"Herath","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"key\n\t\t\t\t20180403061358_kwx359C14","doi-asserted-by":"crossref","first-page":"e0121257","DOI":"10.1371\/journal.pone.0121257","article-title":"Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis","volume":"10","author":"Ni","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"key\n\t\t\t\t20180403061358_kwx359C15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000315394","article-title":"Clarithromycin use and risk of death in patients with ischemic heart disease","volume":"116","author":"Andersen","year":"2010","journal-title":"Cardiology"},{"issue":"2","key":"key\n\t\t\t\t20180403061358_kwx359C16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bcp.12983","article-title":"Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs","volume":"82","author":"Root","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180403061358_kwx359C17","doi-asserted-by":"crossref","first-page":"h6926","DOI":"10.1136\/bmj.h6926","article-title":"Cardiovascular outcomes associated with use of clarithromycin: population based study","volume":"352","author":"Wong","year":"2016","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180403061358_kwx359C18","doi-asserted-by":"crossref","first-page":"f1235","DOI":"10.1136\/bmj.f1235","article-title":"Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies","volume":"346","author":"Schembri","year":"2013","journal-title":"BMJ"},{"issue":"7 suppl","key":"key\n\t\t\t\t20180403061358_kwx359C19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 suppl","key":"key\n\t\t\t\t20180403061358_kwx359C20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 suppl","key":"key\n\t\t\t\t20180403061358_kwx359C21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 suppl","key":"key\n\t\t\t\t20180403061358_kwx359C22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish Register of Causes of Death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"3","key":"key\n\t\t\t\t20180403061358_kwx359C23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","article-title":"Indications for propensity scores and review of their use in pharmacoepidemiology","volume":"98","author":"Glynn","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key\n\t\t\t\t20180403061358_kwx359C24","first-page":"214","author":"Parson","year":"2001"},{"issue":"3","key":"key\n\t\t\t\t20180403061358_kwx359C25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/EDE.0b013e318289dedf","article-title":"Matching by propensity score in cohort studies with three treatment groups","volume":"24","author":"Rassen","year":"2013","journal-title":"Epidemiology"},{"issue":"9","key":"key\n\t\t\t\t20180403061358_kwx359C26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/aje\/kwi106","article-title":"Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly","volume":"161","author":"St\u00fcrmer","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"suppl 3","key":"key\n\t\t\t\t20180403061358_kwx359C27","first-page":"S669","article-title":"Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial","volume":"84","author":"Leowattana","year":"2001","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"key\n\t\t\t\t20180403061358_kwx359C28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/euhj.1998.1283","article-title":"Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study","volume":"20","author":"Gurfinkel","year":"1999","journal-title":"Eur Heart J"},{"issue":"9","key":"key\n\t\t\t\t20180403061358_kwx359C29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.CIR.0000054613.57105.06","article-title":"Antibiotic therapy after acute myocardial infarction: a prospective randomized study","volume":"107","author":"Zahn","year":"2003","journal-title":"Circulation"},{"issue":"9274","key":"key\n\t\t\t\t20180403061358_kwx359C30","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(00)05181-3","article-title":"Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial","volume":"357","author":"Neumann","year":"2001","journal-title":"Lancet"},{"issue":"13","key":"key\n\t\t\t\t20180403061358_kwx359C31","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/01.CIR.0000012544.07696.1F","article-title":"Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-Q-wave coronary syndrome","volume":"105","author":"Sinisalo","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"key\n\t\t\t\t20180403061358_kwx359C32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00228-011-1201-6","article-title":"Fluoroquinolone-induced liver injury: three new cases and a review of the literature","volume":"68","author":"Licata","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"key\n\t\t\t\t20180403061358_kwx359C33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0895-4356(02)00591-7","article-title":"The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry","volume":"56","author":"Madsen","year":"2003","journal-title":"J Clin Epidemiol"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/187\/4\/777\/24528173\/kwx359.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T10:18:45Z","timestamp":1522750725000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/187\/4\/777\/4636594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,11,16]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwx359","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2017,11,16]]}}}